These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8078839)

  • 21. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview.
    Reissmann T; Felberbaum R; Diedrich K; Engel J; Comaru-Schally AM; Schally AV
    Hum Reprod; 1995 Aug; 10(8):1974-81. PubMed ID: 8567825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone and its clinical applications.
    Loucopoulos A; Ferin M
    Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gonadotropin releasing hormone and analogs. Physiology and pharmacology].
    Kiesel L; Runnebaum B
    Gynakol Geburtshilfliche Rundsch; 1992; 32(1):22-30. PubMed ID: 1325231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
    Schwartz NB
    Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIH conference. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs.
    Cutler GB; Hoffman AR; Swerdloff RS; Santen RJ; Meldrum DR; Comite F
    Ann Intern Med; 1985 May; 102(5):643-57. PubMed ID: 3920942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GnRH agonists-antagonists--clinical applications.
    Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):109-16. PubMed ID: 2969835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uses of GnRH agonists.
    Garner C
    J Obstet Gynecol Neonatal Nurs; 1994 Sep; 23(7):563-70. PubMed ID: 7996307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?
    Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
    Gynecol Endocrinol; 2012 Jun; 28(6):422-4. PubMed ID: 22578028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents.
    Lemay A; Surrey ES; Friedman AJ
    Fertil Steril; 1994 Jan; 61(1):21-34. PubMed ID: 8293841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
    Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A
    J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
    Werlin LB; Hodgen GD
    J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
    Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-releasing hormone and its analogs.
    Conn PM; Crowley WF
    Annu Rev Med; 1994; 45():391-405. PubMed ID: 8198390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical applications of LHRH analogues.
    Fraser HM; Baird DT
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):43-70. PubMed ID: 3109366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical aspects of LHRH analogues in gynaecology: a review.
    McLachlan RI; Healy DL; Burger HG
    Br J Obstet Gynaecol; 1986 May; 93(5):431-54. PubMed ID: 3085705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.